PlainRecalls
FDA Drug Low Class III Terminated

Lamivudine Tablets, USP, 150 mg, 30 (3x10) count Unit Dose Blisters Carton, NDC 60687-362-21 (Individual Dose NDC: 60687-362-11), Distributed by American Health Packaging, Columbus, OH

Reported: September 18, 2019 Initiated: August 27, 2019 #D-1847-2019

Product Description

Lamivudine Tablets, USP, 150 mg, 30 (3x10) count Unit Dose Blisters Carton, NDC 60687-362-21 (Individual Dose NDC: 60687-362-11), Distributed by American Health Packaging, Columbus, OH

Reason for Recall

Labeling: Incorrect or Missing Package Insert; an error in the Dosage Forms and Strengths section of the insert that incorrectly lists the tablet description coding for the tablets.

Details

Recalling Firm
American Health Packaging
Units Affected
60 cartons
Distribution
Nationwide
Location
Columbus, OH

Frequently Asked Questions

What product was recalled?
Lamivudine Tablets, USP, 150 mg, 30 (3x10) count Unit Dose Blisters Carton, NDC 60687-362-21 (Individual Dose NDC: 60687-362-11), Distributed by American Health Packaging, Columbus, OH. Recalled by American Health Packaging. Units affected: 60 cartons.
Why was this product recalled?
Labeling: Incorrect or Missing Package Insert; an error in the Dosage Forms and Strengths section of the insert that incorrectly lists the tablet description coding for the tablets.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 18, 2019. Severity: Low. Recall number: D-1847-2019.